Cutera Launches its New Pearl Fractional Device
Cutera today announced regulatory clearance and the commencement of shipments for its newest product, Pearl Fractional, a fractional resurfacing laser.
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced regulatory clearance and the commencement of shipments for its newest product, Pearl Fractional. The company will now begin sales and marketing activities in the United States, Europe and Australia. Pearl Fractional, with its proprietary 2790 nm wavelength, is Cutera’s unique solution for the fast-growing fractional ablative market.
“Pearl Fractional targets the deep dermis to treat the signs of aging,” said Kevin Connors, president and CEO of Cutera. “Our team recognized the limitations of CO2 fractional lasers and designed our product to deliver a better experience to patients and physicians. Pearl Fractional produces a confined thermal zone in the dermis with the goal of reducing post-operative downtime, which we believe will result in greater patient interest.”
Connors continued, “Cutera has consistently developed breakthrough products to treat damage caused by aging, and we now have the most comprehensive anti-aging solutions in the market, with Pearl Fractional joining our Pearl, Titan, LimeLight and Laser Genesis therapies.”
“Cutera is the first and only provider of the 2790 nm wavelength in aesthetic devices,” Connors added. “This new technology is resonating well with our researchers, customers, and in particular, our core market of plastic surgeons and dermatologists.”
“Pearl Fractional is an exciting new application because it optimizes the ratio of ablation and coagulation, while controlling thermal damage,” said David J. Goldberg, MD. “My patients are delighted that they see cosmetic improvements in a single treatment, while experiencing an advanced, safe procedure with an expected recovery time of less than one week.”
Dr. Goldberg continued, “My new Pearl Fractional complements my Pearl laser, giving me a total solution for treating wrinkles, uneven texture, pore size, pigmentation and sun damage.”
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to successfully develop, manufacture, market, sell and service new products worldwide to both its installed base and new customers are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include its ability to increase revenue, manage expenses and improve sales productivity and performance worldwide; its ability to successfully develop and acquire new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to its operations; government regulatory actions; general economic conditions; and those other factors described in the section entitled, “Risk Factors,” in its most recent Form 10-Q as filed with the Securities and Exchange Commission on August 4, 2008. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.